JPRN-UMIN000053151尚未招募Unknown
Fetroja for Intravenous Drip Infusion Regular Drug Use-results Survey - Fetroja for Intravenous Drip Infusion Regular Drug Use-results Survey
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
不适用
HEMLIBRA Subcutaneous injection General Drug Use Surveillance(in Hemophilia A with Inhibitors).Hemophilia AJPRN-UMIN000032515Chugai Pharmaceutical Co. Ltd.100
已完成
不适用
HEMLIBRA Subcutaneous injection Special Drug Use Surveillance (with Hemophilia A without Inhibitors).Hemophilia AJPRN-UMIN000037503Chugai Pharmaceutical Co. Ltd.87
进行中（未招募）
不适用
Intravenous ferric carboxymaltose (Ferinject®) with or without Erythropoietin for the correction of preoperative anaemia in patients undergoing orthopaedic surgery•To evaluate the effect of the administration of ferric carboxymaltose (Ferinject®) with or without erythropoietin vs. no treatment (standard therapy) on the preoperative anaemia status in patients undergoing orthopaedic surgery •To gain informations for the design of a possible follow-up study•.•To evaluate the tolerability and safety of Ferinject®EUCTR2009-015799-92-ATniversitätspital Zürich Anästhesie75
招募中
不适用
HEMLIBRA Subcutaneous Injection, General drug use-results survey - Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with acquired hemophilia ARoutine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with acquired hemophilia AJPRN-UMIN000048156Chugai Pharmaceutical Co. Ltd.150
已完成
不适用
Does the administration of intravenous (IV) fluids intra-operatively reduce the incidence of post-operative nausea and vomiting in children undergoing day-surgery?ausea and vomitingsurgerySurgeryISRCTN89982548Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)300